SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-463220
Filing Date
2012-11-09
Accepted
2012-11-09 15:57:13
Documents
10
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d410718d10q.htm 10-Q 580629
2 CERTIFICATION OF NEKTAR THERAPEUTICS' PRINCIPAL EXECUTIVE OFFICER d410718dex311.htm EX-31.1 10039
3 CERTIFICATION OF NEKTAR THERAPEUTICS' PRINCIPAL FINANCIAL OFFICER d410718dex312.htm EX-31.2 10038
4 SECTION 1350 CERTIFICATIONS d410718dex321.htm EX-32.1 5044
  Complete submission text file 0001193125-12-463220.txt   3962439

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT nktr-20120930.xml EX-101.INS 532675
6 XBRL TAXONOMY EXTENSION SCHEMA nktr-20120930.xsd EX-101.SCH 54414
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nktr-20120930_cal.xml EX-101.CAL 31130
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nktr-20120930_def.xml EX-101.DEF 216856
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE nktr-20120930_lab.xml EX-101.LAB 327456
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nktr-20120930_pre.xml EX-101.PRE 256425
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-24006 | Film No.: 121193597
SIC: 2834 Pharmaceutical Preparations